Published in AIDS Weekly, April 29th, 1996
The U.S. Food and Drug Administration (FDA) approved the device, which delivers a steady dose of the drug ganciclovir sodium directly into the eye infected with CMV. CMV infection also occurs, although less frequently, in organ-transplant patients taking immunosuppressive drugs.
"CMV has a tendency to infect the retina and destroy it. Since the retina is the light sensing tissue in the eye, CMV infection there can cause permanent,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.